|
THERAPEUTIC USE OF AN INHIBITOR OF A
HEDGEHOG SIGNALLING PATHWAY
European Patent
EP1183040
Use of an inhibitor
of a Hedgehog signalling pathway, or an
inhibitor of a pathway which is a target of the
Hedgehog signalling pathway in the preparation
of a medicament for treatment of epithelial cell
hyperplasia, fibrosis of tissue, inflammation,
cancer or an immune disorder. Also a transgenic
animal or cell line capable of expressing a
component or an inhibitor of a hedgehog
signalling pathway or a target pathway of the
hedgehog signalling pathway. |
